 |
|
Researchers say estrogen can kill breast cancer cells once fueled by the hormone
December 07, 2005Fox Chase Cancer Center researchers say some breast cancer cells once fueled by estrogen can be killed by the same hormone. This raises the possibility that estrogen therapy after estrogen deprivation may overcome the cells' eventual resistance to hormone therapy. The finding by V. Craig Jordan, Ph.D., D. Sc., and his colleagues at Fox Chase is published in the December 7 issue of the Journal of the National Cancer Institute.
Many breast cancer cells (called estrogen receptor-positive breast cancers) require estrogen for survival. Women with these types of breast cancers are treated with drugs that that block estrogen, such as tamoxifen, fulvestrant, or aromatase inhibitors, causing the cells to die in a process called apoptosis. However, over time, these cancer cells learn to adapt and become resistant to this therapy.
"Tamoxifen and other estrogen inhibition drugs have been remarkably successful in the treatment of hormone-responsive breast cancers," said Jordan, vice president and scientific director for the medical science division at Fox Chase. "However, cancer cells are smart and they figure out how to survive these treatments. We believe we've become savvy to their art. Our laboratory study demonstrates that these same breast cancer cells die when we re-introduce them to estrogen." Jordan was the leader in the development of the use of tamoxifen to treat breast cancer. He holds the Alfred G. Knudson Jr., M.D., Ph.D., Chair in Cancer Research at Fox Chase.
The mechanism by which estrogen promotes apoptosis is not well understood. To understand this process, Jordan and his colleagues developed a line of breast cancer cells, called MCF-7:5C. These cells already are resistant to estrogen withdrawal. When the researchers treated MCF-7:5C cells with very small concentrations of estradiol they underwent apoptosis. The researchers also tested these cells in mice to see how this process might influence existing tumors. Again, the exposure to estradiol caused the cancer cells to die.
"These laboratory data have important clinical implications, particularly for the use of aromatase inhibitors as long-term therapy," write the authors, "and they suggest that, if and when resistance to aromatase inhibition occurs, a strategy of treatment with estrogen may be sufficient to kill the cancer and control disease progression."
Fox Chase Cancer Center
The mechanism by which estrogen promotes apoptosis is not well understood. To understand this process, Jordan and his colleagues developed a line of breast cancer cells, called MCF-7:5C. These cells already are resistant to estrogen withdrawal. When the researchers treated MCF-7:5C cells with very small concentrations of estradiol they underwent apoptosis. The researchers also tested these cells in mice to see how this process might influence existing tumors. Again, the exposure to estradiol caused the cancer cells to die.
"These laboratory data have important clinical implications, particularly for the use of aromatase inhibitors as long-term therapy," write the authors, "and they suggest that, if and when resistance to aromatase inhibition occurs, a strategy of treatment with estrogen may be sufficient to kill the cancer and control disease progression."
Fox Chase Cancer Center
Breast Cancer Cells News and Current Breast Cancer Cells Events RSSM. D. Anderson study finds change in HER2 status after treatment with Herceptin
Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery.
Dense tissue promotes aggressive cancers
New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue. Breast cancer cells grown in dense, rigid surroundings step up their invasive activities, Vanderbilt-Ingram Cancer Center investigators report in the Sept. 9 issue of Current Biology.
Vitamin A pushes breast cancer to form blood vessel cells
Researchers at Georgetown University Medical Center have discovered that vitamin A, when applied to breast cancer cells, turns on genes that can push stem cells embedded in a tumor to morph into endothelial cells. These cells can then build blood vessels to link up to the body's blood supply, promoting further tumor growth.
Cancer 'cure' in mice to be tested in humans
Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice.
Laser Surgery Probe Targets Individual Cancer Cells
Mechanical engineering Assistant Professor Adela Ben-Yakar at The University of Texas at Austin has developed a laser "microscalpel" that destroys a single cell while leaving nearby cells intact, which could improve the precision of surgeries for cancer, epilepsy and other diseases.
Absence or low function of CHFR gene in breast cells sets stage for abnormal cell division and cancer
A University of Michigan study reveals in detail how breast cells produce new cells that are predisposed to become cancerous, unless they receive the protective action of the CHFR gene.
New Cancer Treatment Targets Both Tumor Cells and Blood Vessels
It takes more than one punch to fight tumors. Often, tumors have more than one way of surviving, and attacking the tumor alone is not enough.
Ability to track stem cells in tumors could advance cancer treatments
Using noninvasive molecular imaging technology, a method has been developed to track the location and activity of mesenchymal stem cells (MSCs) in the tumors of living organisms.
Previously unseen switch regulates breast cancer response to estrogen
A tiny modification called methylation on estrogen receptors prolongs the life of these growth-driving molecules in breast cancer cells, according to research by scientists at Emory University's Winship Cancer Institute.
Predicting breast cancer patient outcome: MUHC researchers identify new genes
Not a day goes by without a new story about the environment. Although we often consider the environment on a global scale, cells in our body also have to contend with environmental factors.
More Breast Cancer Cells News Articles
 | Cancer Imaging, Volume 1-2 by M. A. Hayat With cancer related deaths projected to rise to 10.3 million people by 2020, the need to prevent, diagnose, and cure cancer is greater than ever. These two volumes present readers with the most up-to-date imaging instrumentation, general and diagnostic applications for various cancers. Both volumes discuss the various imaging techniques used to locate and diagnose tumors, including ultrasound,... |
 | Mammary Tumor Cell Cycle, Differentiation and Metastasis: Advances in Cellular and Molecular Biology of Breast Cancer (Cancer Treatment and Research) Mammary Tumor Cell Cycle, Differentiation and Metastasis is the fifth volume since 1988 in a series designed to broadly examine current advances in the cellular and molecular biology of breast cancer. As in previous volumes, the editors have invited recognized experts in cutting-edge topics to provide a chapter focused on their area of research. The editors have turned to the researchers who... |
 | Chemosensitivity Testing in Oncology (Recent Results in Cancer Research) The last decade has seen a renaissance of the concept of individualized chemotherapy in oncology, markedly stimulated by the development of new in vitro chemosensitivity assays. The clinical utility of drug response assays has been evaluated in clinical trials and the results suggest that assay-assisted therapy selection may improve survival as well as economic outcomes. This volume comprises the... |
 | Cancer Imaging, Volume 1: Lung and Breast Carcinomas (Cancer Imaging) (Cancer Imaging) by M. A. Hayat This two-volume reference book will present imaging technology currently used in clinics or at experimental stages for diagnosis and/or early detection of various cancers, including anticancer vaccines, surgical techniques, chemotherapy, radiation, and gene therapies. Cancers discussed will include breast, lung, liver, prostate, cervical, brain, gastrointestinal, ovarian, gallbladder, esophageal,... |
 | Hormonal Control of Cell Cycle (Research and Perspectives in Endocrine Interactions) The topics range from fundamental studies of DNA replication, chromosomal and nuclear function through growth factor control of endocrine tumor initiation and progression. The basic and translational insights gained from this book will be of interest to those studying the biology of endocrine tumors, as well as those deriving novel therapeutic approaches for these benign and malignant disorders.... |
| Circulating tumor cells signal outcome in metastatic breast ca.(Gynecology): An article from: OB GYN News by Bruce Jancin This digital document is an article from OB GYN News, published by International Medical News Group on April 1, 2005. The length of the article is 524 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| No survival benefit for high-dose chemo plus stem cell transplant for advanced breast cancer.: An article from: Transplant News This digital document is an article from Transplant News, published by Transplant Communications, Inc. on July 25, 2003. The length of the article is 459 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Effects of Citrus aurantifolia concentrated extract on the spontaneous proliferation of MDA-MB-453 and RPMI-8866 tumor cell lines. (Short Communication).: ... Journal of Phytotherapy & Phytopharmacology by M. Gharagozloo, M. Doroudchi, A. Ghaderi This digital document is an article from Phytomedicine: International Journal of Phytotherapy & Phytopharmacology, published by Urban & Fischer Verlag on July 1, 2002. The length of the article is 2264 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You... | |
| Hormones and Cancer 2: Proceedings of the Second International Congress on Hormones and Cancer (Progress in Cancer Research and Therapy, V. 31) by Monaco) International Congress on Hormones and Cancer (2nd : 1983 : Monte Carlo, Francesco Bresciani | |
 | Hormonal Carcinogenesis V (Advances in Experimental Medicine and Biology) (Advances in Experimental Medicine and Biology) Information gathered from cell-free systems, cell cultures, animal models, and human studies, together will (1) provide important insights to our understanding of hormonal cancer causation, development, and prevention; (2) be the primary objective of these... |
| © 2008 BrightSurf.com |